{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:54Z","timestamp":1777983894398,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42497-w","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:15:40Z","timestamp":1772878540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Key hub genes identification and therapeutic target prediction via multi-validation for the senescence-inflammation axis in prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u2019ang\u2019shu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"2","key":"42497_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/imm.13456","volume":"168","author":"D Feng","year":"2023","unstructured":"Feng, D., Xiong, Q., Wei, Q. & Yang, L. Cellular landscape of tumour microenvironment in prostate cancer. Immunology 168 (2), 199\u2013202 (2023).","journal-title":"Immunology"},{"issue":"6","key":"42497_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","volume":"46","author":"M Nguyen-Nielsen","year":"2016","unstructured":"Nguyen-Nielsen, M. & Borre, M. Diagnostic and Therapeutic Strategies for Prostate Cancer. Semin Nucl. Med. 46 (6), 484\u2013490 (2016).","journal-title":"Semin Nucl. Med."},{"issue":"3","key":"42497_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/CCO.0000000000000519","volume":"31","author":"A Kaiser","year":"2019","unstructured":"Kaiser, A., Haskins, C., Siddiqui, M. M., Hussain, A. & D\u2019Adamo, C. The evolving role of diet in prostate cancer risk and progression. Curr. Opin. Oncol. 31 (3), 222\u2013229 (2019).","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"42497_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","volume":"27","author":"TR Rebbeck","year":"2017","unstructured":"Rebbeck, T. R. Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Semin Radiat. Oncol. 27 (1), 3\u201310 (2017).","journal-title":"Semin Radiat. Oncol."},{"issue":"Suppl 1(Suppl 1","key":"42497_CR5","first-page":"S86","volume":"82","author":"K Mizuno","year":"2022","unstructured":"Mizuno, K. & Beltran, H. Future directions for precision oncology in prostate cancer. Prostate 82 (Suppl 1(Suppl 1), S86\u2013s96 (2022).","journal-title":"Prostate"},{"issue":"S3","key":"42497_CR6","first-page":"24","volume":"27","author":"A Uhr","year":"2020","unstructured":"Uhr, A., Glick, L. & Gomella, L. G. An overview of biomarkers in the diagnosis and management of prostate cancer. Can. J. Urol. 27 (S3), 24\u201327 (2020).","journal-title":"Can. J. Urol."},{"issue":"1","key":"42497_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso, A. & Epstein, J. I. Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74 (1), 135\u2013145 (2019).","journal-title":"Histopathology"},{"issue":"1","key":"42497_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12967-022-03459-8","volume":"20","author":"D Feng","year":"2022","unstructured":"Feng, D. et al. A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. J. Transl Med. 20 (1), 252 (2022).","journal-title":"J. Transl Med."},{"issue":"12","key":"42497_CR9","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Copp\u00e9","year":"2008","unstructured":"Copp\u00e9, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6 (12), 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"issue":"1","key":"42497_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/2159-8290.CD-RW2020-169","volume":"11","author":"TIMP1","year":"2021","unstructured":"TIMP1. Determines the Effects of Cellular Senescence in Prostate Cancer. Cancer Discov. 11 (1), 12 (2021).","journal-title":"Cancer Discov"},{"issue":"5","key":"42497_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s43587-021-00063-1","volume":"1","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype. Nat. Aging. 1 (5), 454\u2013472 (2021).","journal-title":"Nat. Aging"},{"issue":"8","key":"42497_CR12","first-page":"3811","volume":"12","author":"D Feng","year":"2022","unstructured":"Feng, D. et al. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer. Am. J. Cancer Res. 12 (8), 3811\u20133828 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"42497_CR13","doi-asserted-by":"publisher","first-page":"1169425","DOI":"10.3389\/fonc.2023.1169425","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. An anoikis-related gene signature for prediction of the prognosis in prostate cancer. Front. Oncol. 13, 1169425 (2023).","journal-title":"Front. Oncol."},{"key":"42497_CR14","doi-asserted-by":"publisher","first-page":"1126902","DOI":"10.3389\/fimmu.2023.1126902","volume":"14","author":"C Han","year":"2023","unstructured":"Han, C. et al. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer. Front. Immunol. 14, 1126902 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"42497_CR15","doi-asserted-by":"publisher","first-page":"e13169","DOI":"10.1111\/and.13169","volume":"51","author":"W Lu","year":"2019","unstructured":"Lu, W. & Ding, Z. Identification of key genes in prostate cancer gene expression profile by bioinformatics. Andrologia 51 (1), e13169 (2019).","journal-title":"Andrologia"},{"key":"42497_CR16","doi-asserted-by":"publisher","first-page":"1084531","DOI":"10.3389\/fimmu.2023.1084531","volume":"14","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning. Front. Immunol. 14, 1084531 (2023).","journal-title":"Front. Immunol."},{"key":"42497_CR17","doi-asserted-by":"publisher","first-page":"102111","DOI":"10.1016\/j.arr.2023.102111","volume":"92","author":"L Ye","year":"2023","unstructured":"Ye, L. et al. Frailty and sarcopenia: A bibliometric analysis of their association and potential targets for intervention. Ageing Res. Rev. 92, 102111 (2023).","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"42497_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"1","key":"42497_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek, D., Morris, J. H., Bou\u00e7as, J., Pico, A. R. & Demchak, B. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 20 (1), 185 (2019).","journal-title":"Genome Biol."},{"key":"42497_CR20","doi-asserted-by":"publisher","first-page":"667690","DOI":"10.3389\/fimmu.2021.667690","volume":"12","author":"W Su","year":"2021","unstructured":"Su, W. et al. Exploring the Pathogenesis of Psoriasis Complicated With Atherosclerosis via Microarray Data Analysis. Front. Immunol. 12, 667690 (2021).","journal-title":"Front. Immunol."},{"issue":"8","key":"42497_CR21","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/glia.23330","volume":"66","author":"A Eraso-Pichot","year":"2018","unstructured":"Eraso-Pichot, A. et al. GSEA of mouse and human mitochondriomes reveals fatty acid oxidation in astrocytes. Glia 66 (8), 1724\u20131735 (2018).","journal-title":"Glia"},{"issue":"D1","key":"42497_CR22","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45 (D1), D353\u2013d361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"42497_CR23","doi-asserted-by":"publisher","first-page":"1056750","DOI":"10.3389\/fimmu.2022.1056750","volume":"13","author":"J Fan","year":"2022","unstructured":"Fan, J., Shi, S., Qiu, Y., Liu, M. & Shu, Q. Analysis of signature genes and association with immune cells infiltration in pediatric septic shock. Front. Immunol. 13, 1056750 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"42497_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12885-023-10685-w","volume":"23","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling. BMC Cancer. 23 (1), 280 (2023).","journal-title":"BMC Cancer"},{"issue":"1","key":"42497_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13578-022-00941-0","volume":"12","author":"J Kallenbach","year":"2022","unstructured":"Kallenbach, J., Atri Roozbahani, G., Heidari Horestani, M. & Baniahmad, A. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. Cell. Biosci. 12 (1), 200 (2022).","journal-title":"Cell. Biosci."},{"issue":"1","key":"42497_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","volume":"39","author":"I Guccini","year":"2021","unstructured":"Guccini, I. et al. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis. Cancer Cell. 39 (1), 68\u201382e69 (2021).","journal-title":"Cancer Cell."},{"issue":"7","key":"42497_CR27","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.21037\/tcr-22-1301","volume":"11","author":"D Ko\u0142at","year":"2022","unstructured":"Ko\u0142at, D., Kciuk, M., K\u0142osi\u0144ski, K. & Ka\u0142uzi\u0144ska, \u017b. Pyroptosis-related signatures in bladder cancer prognosis and treatment-are we there yet? Transl Cancer Res. 11 (7), 1861\u20131864 (2022).","journal-title":"Transl Cancer Res."},{"key":"42497_CR28","doi-asserted-by":"crossref","unstructured":"Lia, T., Shao, Y., Regmi, P. & Li, X. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer. Biosci. Rep. 42 (1). (2022).","DOI":"10.1042\/BSR20212253"},{"key":"42497_CR29","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.2147\/IJGM.S337735","volume":"14","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer. Int. J. Gen. Med. 14, 8109\u20138120 (2021).","journal-title":"Int. J. Gen. Med."},{"issue":"9","key":"42497_CR30","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1002\/cam4.1695","volume":"7","author":"KA Cavassani","year":"2018","unstructured":"Cavassani, K. A. et al. Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells. Cancer Med. 7 (9), 4639\u20134649 (2018).","journal-title":"Cancer Med."},{"key":"42497_CR31","doi-asserted-by":"publisher","first-page":"1426474","DOI":"10.3389\/fimmu.2024.1426474","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy. Front. Immunol. 15, 1426474 (2024).","journal-title":"Front. Immunol."},{"key":"42497_CR32","doi-asserted-by":"publisher","first-page":"586126","DOI":"10.3389\/fimmu.2020.586126","volume":"11","author":"M Gallazzi","year":"2020","unstructured":"Gallazzi, M. et al. Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors. Front. Immunol. 11, 586126 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"42497_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/nyas.13372","volume":"1403","author":"A Kumar","year":"2017","unstructured":"Kumar, A., Rimando, A. M. & Levenson, A. S. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer. Ann. N Y Acad. Sci. 1403 (1), 15\u201326 (2017).","journal-title":"Ann. N Y Acad. Sci."},{"issue":"6","key":"42497_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1078-1439(02)00194-1","volume":"7","author":"HL Ratan","year":"2002","unstructured":"Ratan, H. L., Steward, W. P., Gescher, A. J. & Mellon, J. K. Resveratrol\u2013a prostate cancer chemopreventive agent? Urol. Oncol. 7 (6), 223\u2013227 (2002).","journal-title":"Urol. Oncol."},{"issue":"1","key":"42497_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jox11010002","volume":"11","author":"N Silk","year":"2021","unstructured":"Silk, N. et al. The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment. J. Xenobiot. 11 (1), 16\u201332 (2021).","journal-title":"J. Xenobiot"},{"issue":"12","key":"42497_CR36","doi-asserted-by":"publisher","first-page":"e15627","DOI":"10.1371\/journal.pone.0015627","volume":"5","author":"S Ganapathy","year":"2010","unstructured":"Ganapathy, S., Chen, Q., Singh, K. P., Shankar, S. & Srivastava, R. K. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One. 5 (12), e15627 (2010).","journal-title":"PLoS One"},{"key":"42497_CR37","doi-asserted-by":"crossref","unstructured":"Kuan, F. C., Li, J. M., Huang, Y. C., Chang, S. F. & Shi, C. S. Therapeutic potential of regorafenib in cisplatin-resistant bladder cancer with high epithelial-mesenchymal transition and stemness properties. Int. J. Mol. Sci. 24 (24). (2023).","DOI":"10.3390\/ijms242417610"},{"issue":"9","key":"42497_CR38","first-page":"4919","volume":"37","author":"FT Hsu","year":"2017","unstructured":"Hsu, F. T. et al. Regorafenib Induces Apoptosis and Inhibits Metastatic Potential of Human Bladder Carcinoma Cells. Anticancer Res. 37 (9), 4919\u20134926 (2017).","journal-title":"Anticancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42497-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T11:01:49Z","timestamp":1776596509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42497-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42497-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6305197\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by the Ethics Committee of Medical Ethics Committee of Chengdu University Affiliated Hospital (ethics approval number PJ2023-109-15). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"12512"}}